Archive for category: emptywheel

For some strange reason, I have the distinct pleasure of getting the Chris Matthews Show, the syndicated half hour one, before most folks, on Saturday afternoon at 5:00 pm local time. What a constant thrill. Today Matthews had on the sage panel of Joe Klein TIME; Norah O’Donnell MSNBC; Anne Kornblut The Washington Post; and David Ignatius The Washington Post.

It did not disappoint – they all predicted Sarah Palin was the force to be reckoned with for the 2012 Republican nomination and that Barack Obama was in trouble.

The village elders are village idiots.

Instead how about both the cognoscenti and citizens of the fine United States of America ponder an ethos more along the lines contemplated by our friend Mary:

To go back to one of the lesser points – the GITMO pics – one of the reasons that everyone knows they are not being released is that they demonstrate several direct lies formerly made by the Executive to the American people. Lies about the extent of abuse, lies about prosecutions of abusers, lies about a few rogue soldiers v. a planned regime of torture, etc. Not only lies, but suppression of evidence of crime leading to obstruction of justice as a) torturers were not brought to justice for their crimes against innocent civilian populations, and b) Abu Ghraib soldiers were scapegoated and railroaded in a sideshow event specifically calculated to use them as a shield against further investigation. So Obama furthers the obstruction, picture frames his “no one is above the law” campaign promise as being an outright lie, and then uses the Executive office to attack the judiciary. Not content, he permeates the whole of the Democratic majority with his torture support by strongarming (in a rare leadership moment) Democratic legislation to subvert justice. That’s not pragmatism, it’s how you lose support and votes.

The truth is that Americans do respond to the truth when battered with it as frequently as with the opposition talking points. He’s never once utilized his position to do that – to got there – to be truthful about what has happened on torture, what is happening with innocent men being held at GITMO, what the *mission* is in the ME, etc. Let me put it this way – if I can make Indiana red necks blink and flinch with just a few facts, Obama giving a Presidential address, early on, to admit that bc of poor policies, intermingled with some very evil and bad men at GITMO, there are some innocent victims who should never have been sent there — yes, there would have been right wing furor (as always – I think that also happens when he goes out to dinner for that matter) but there would have been a big conscious shifting moment for the country and a seismic change in how the Muslim world sees us.

Instead, he opted to be Bush Jr. Not only is that not pragmatic, it’s a slow kill poisen. All the people who never wanted him still don’t want him; those who thought he would be something are now thoroughly jaded to not just Obama the candidate, but the Democratic “like Bush, but comes in blue” party. Read more →

Just in case you haven’t been following Balkinization since Marty Lederman went to work at DOJ, I wanted to link to this Jon Hafetz* post, which hits on a lot of the points that powwow and Mary raised in this thread yesterday.

But at Guantánamo, the road to justice remains the road less traveled. Holder also announced that five other Guantánamo detainees would be referred back to military commissions, including Abd al-Rahim al-Nashiri, the alleged mastermind of the 2000 bombing of the USS Cole. So, those accused of the 9/11 attacks go to civilian court, while those accused of other crimes are diverted to military commissions. Yes, al-Nishiri is accused of attacking a military target. But the attack occurred before the United States was engaged in any armed conflict and before the passage of the Authorization for Use of Military Force that the U.S. has relied on for the claimed armed conflict against al Qaeda. (In Hamdan, Justice Stevens described such retroactive use of military commissions as “insupportable”). As Deborah Pearlstein points out , the administration has failed to provide a consistent, let alone valid, legal theory why one case goes to a military commission and another to federal court—why one prisoner gets full due process in a federal trial while another receives due process lite in a refurbished commission. Military commissions may have a place in the limited circumstances of true necessity—where the civilian courts are not open, functioning, and capable of dispensing justice. But military “necessity” is not an excuse for the government to deviate from its regularly constituted courts because it lacks the evidence to convict. And even if that were not the reason (or the only reason) for using military commissions, it will be the enduring perception of America’s two-tiered system of justice.

Holder’s announcement, moreover, deals only with one slice of Guantánamo. In the eight years since President Bush first created military commissions, only three men have been tried by these supposed “war courts.” By contrast, more than 750 have been detained without trial and more than 200 remain in legal limbo. Military commissions have helped mask a much larger system of prolonged and indefinite detention without charge. This open-ended detention system has been one of the most brutal, arbitrary, and lawless aspects of Guantánamo.

Click through for the rest, including where Hafetz argues that, “U.S. detention policy will remain essentially lawless.”

---

*Mary (!) will be hosting an FDL Book Salon with Hafetz and Mark Denbeaux for a discussion of their book, The Guantanamo Lawyers: Inside a Prison Outside the Law on December 19.

As the NYT reported earlier today, Genentech/Roche wrote a Republican script and a Democratic script for its parrots to enter into the Congressional Record. Here’s what the Republican script looks like (I’m going to try to do the Democratic one next–but this is tedious stuff; and yes, Heath Shuler was working from the Republican script).

“I oppose this bill but love the appropriate balance it gives to monopolistic biologics”

Joe Wilson

I have criticized many of the provisions of this bill (H.R. 3962) and rightfully so. But in fairness, I do believe the sections relating to the creation of a market for biosimilar products is one area of the bill that strikes the appropriate balance in providing lower cost options to consumers without destroying a healthy and functioning industry in this country.

Jerry Moran

Mr. Speaker, after reviewing H.R. 3962, the Affordable Health Care for America Act, listening to the concerns of Kansans, and visiting Kansas hospitals to speak with doctors, nurses, patients, and administrators, I have concluded that this bill will be harmful to Kansas and I strongly oppose it. However, I do believe the sections relating to the creation of a market for biosimilar products is one area of the bill that strikes the appropriate balance in providing lower cost options to patients without destroying a healthy and functioning industry in this country.

Kay Granger

Mr. Speaker, I have criticized the majority of the provisions in H.R. 3962, the Affordable Health Care for America Act, and I will vote against it. However, I am pleased that H.R. 3962, as well as the Republican Substitute Amendment that I support, both include language relating to biosimilar products.

Lee Terry

Mr. Speaker, I have criticized many of the provisions of this bill and rightfully so. But in fairness, I do believe the sections relating to the creation of a market for biosimilar products is one area of the bill that strikes the appropriate balance in providing lower cost options to consumers without destroying a healthy and functioning industry in this country.

Ted Poe

I am strongly against H.R. 3962, and I will vote against it should it come to a vote on the House floor. However, I do believe the sections relating to the creation of a market for biosimilar products is one area of the bill that strikes the appropriate balance in providing lower cost options to consumers without destroying a healthy and functioning industry in this country.

Blaine Luetkemeyer

Mr. Speaker, I have criticized many of the provisions of this bill and rightfully so. However, one bi-partisan area that strikes the appropriate balance in providing lower-cost options to consumers without destroying a healthy and functioning industry in this country that is included in both the underlying bill, which I strongly oppose, and the Republican substitute, which I intend to support, are the sections relating to the creation of a market for biosimilar products.

Lynn Jenkins

Mr. Speaker, I have criticized many of the provisions of this bill and rightfully so. However, I do believe the sections relating to the creation of a market for biosimilar products is one area of the bill that strikes the appropriate balance in providing lower cost options to consumers without destroying a healthy and functioning industry in this country.

Mike Conaway

Mr. Speaker, I have criticized many of the provisions of H.R. 3962, the Affordable Health Care for America Act, and with good reason. However, I believe that the creation of a market for biosimilar products is one area of the bill that strikes the appropriate balance in providing lower cost options to consumers without destroying a healthy and functioning industry in this country.

Darrell Issa

Despite this bill’s many faults, I support the bill’s language establishing a market for biosimilars which balances the desire to provide cheaper biologics with the need to continue incentivizing investment in research and development.

Kevin McCarthy

These are some of the many concerns I have with H.R. 3962, which is why I instead support the Republican health care alternative. The alternative excludes the unnecessary and burdensome excise tax in H.R. 3962, and also includes a responsible pathway for follow-on biologics by including provisions from the Pathways for Biosimilars Act, which I am a proud cosponsor of.

[snip]

But we need solutions that strike a balance in reducing health care costs, strengthening health care access, and allowing health innovators, like our biotech industry, to continue to research and improve therapies for patients.

Heath Shuler

Mr. Speaker, as you know I am opposed to the bill we are considering today for many reasons that I have articulated previously. I am pleased, however, that the bill strikes the appropriate balance on the issue of follow on biologics. This bipartisan compromise language will provide lower cost options to consumers and my constituents  without destroying a healthy and functioning bio-tech industry in this country.

Read more →